Immunic (IMUX) Operating Leases (2019 - 2026)

Immunic (IMUX) posted Operating Leases of $421000.0 for Q1 2026, up 293.46% sequentially from $107000.0 in Q4 2025, and down 56.82% YoY from $975000.0 in Q1 2025.

Immunic (IMUX) Operating Leases (2019 - 2026) Analysis & Trends

Immunic has reported Operating Leases for 8 years, with the latest figure at $421000.0 in Q1 2026.

  • Quarterly Operating Leases fell 56.82% year-over-year to $421000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $421000.0 (down 56.82% YoY) and the FY2025 annual result came in at $107000.0, down 59.47% from the prior year.
  • Operating Leases improved to $421000.0 in Q1 2026 per IMUX's latest filing, from $107000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $2.0 million in Q1 2023 and troughed at $107000.0 in Q4 2025.
  • A 5-year average of $785705.9 and a median of $759000.0 in 2022 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2023 and 2024: Operating Leases soared 298.61% in 2023, then sank 87.18% in 2024.
  • Over 5 years, Operating Leases stood at $992000.0 in 2022, then plunged by 35.58% to $639000.0 in 2023, then sank by 58.69% to $264000.0 in 2024, then plunged by 59.47% to $107000.0 in 2025, then jumped by 293.46% to $421000.0 in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $421000.0, $107000.0, and $126000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Immunic 682.77 Mn 682.77 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 567,000.00
Mar 31, 2026 421,000.00
Dec 31, 2025 107,000.00
Sep 30, 2025 126,000.00
Jun 30, 2025 205,000.00
Mar 31, 2025 975,000.00
Dec 31, 2024 264,000.00
Sep 30, 2024 186,000.00
Jun 30, 2024 955,000.00
Mar 31, 2024 1.13 Mn
Dec 31, 2023 639,000.00
Sep 30, 2023 1.45 Mn
Jun 30, 2023 1.88 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 992,000.00
Sep 30, 2022 759,000.00
Jun 30, 2022 767,000.00
Mar 31, 2022 502,000.00
Dec 31, 2021 584,000.00
Sep 30, 2021 701,000.00